Showing results (1-10 of 115) with videos related to
Sort By:
Pageof 12
Clinical Pharmacology and Therapeutics|August 1, 1975
EPEG, a new antineoplastic epipodophyllotoxinP J Creaven, L M AllenClinical Pharmacology and Therapeutics|April 1, 1975
Pharmacokinetics of ifosfamideL M Allen, P J CreavenCancer Treatment Reports|January 1, 1976
Thalicarpine (NSC-68075): plasma decay and urinary excretion in manP J Creaven, L M AllenClinical Pharmacology and Therapeutics|August 1, 1975
PTG, a new antineoplastic epipodyphyllotoxinP J Creaven, L M AllenJournal of Pharmaceutical Sciences|August 1, 1978
Multicompartment pharmacokinetic model of 4'-demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside) in humansF R Pelsor, L M Allen, P J CreavenCancer Treatment Reports|April 1, 1976
Studies on the human pharmacokinetics of isophosphamide (NSC-109724)L M Allen, P J Creaven, R L NelsonThe Journal of Pharmacy and Pharmacology|December 1, 1975
The bioavailability in man of ICRF-159 a new oral antineoplastic agentP J Creaven, L M Allen, D A AlfordClinical Pharmacology and Therapeutics|March 1, 1976
Pharmacokinetics of divided-dose ifosfamideR L Nelson, L M Allen, P J CreavenBritish Journal of Cancer|December 1, 1973
Methotrexate in liver and bile after intravenous dosage in manP J Creaven, H H Hansen, D A Alford, et al.Pageof 12